home / stock / apto / apto short
Short Information | Aptose Biosciences Inc. (NASDAQ:APTO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 227,075 |
Total Actual Volume | 1,501,156 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 11,354 |
Average Short Percentage | 15.12% |
Is there a APTO Short Squeeze or Breakout about to happen?
See the APTO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-25-2024 | $1.19 | $1.16 | $1.235 | $1.15 | 47,081 | 5,487 | 11.65% |
04-24-2024 | $1.26 | $1.22 | $1.26 | $1.2 | 56,221 | 7,225 | 12.85% |
04-23-2024 | $1.23 | $1.23 | $1.278 | $1.2 | 72,321 | 20,972 | 29% |
04-22-2024 | $1.23 | $1.23 | $1.2599 | $1.2101 | 12,898 | 1,382 | 10.71% |
04-19-2024 | $1.24 | $1.231 | $1.285 | $1.23 | 36,438 | 5,523 | 15.16% |
04-18-2024 | $1.25 | $1.27 | $1.29 | $1.25 | 34,780 | 2,874 | 8.26% |
04-17-2024 | $1.27 | $1.26 | $1.34 | $1.2582 | 31,324 | 6,936 | 22.14% |
04-16-2024 | $1.29 | $1.27 | $1.32 | $1.2 | 45,647 | 13,407 | 29.37% |
04-15-2024 | $1.39 | $1.3 | $1.4 | $1.29 | 65,087 | 12,759 | 19.6% |
04-12-2024 | $1.39 | $1.36 | $1.4397 | $1.34 | 35,185 | 3,950 | 11.23% |
04-11-2024 | $1.4 | $1.38 | $1.43 | $1.37 | 51,284 | 7,041 | 13.73% |
04-10-2024 | $1.39 | $1.38 | $1.4758 | $1.38 | 54,000 | 3,570 | 6.61% |
04-09-2024 | $1.48 | $1.41 | $1.49 | $1.4 | 179,377 | 19,386 | 10.81% |
04-08-2024 | $1.45 | $1.47 | $1.52 | $1.38 | 113,186 | 10,061 | 8.89% |
04-05-2024 | $1.41 | $1.38 | $1.4699 | $1.38 | 56,092 | 8,502 | 15.16% |
04-04-2024 | $1.47 | $1.43 | $1.56 | $1.39 | 134,594 | 29,721 | 22.08% |
04-03-2024 | $1.57 | $1.44 | $1.58 | $1.44 | 113,290 | 7,720 | 6.81% |
04-02-2024 | $1.65 | $1.58 | $1.67 | $1.51 | 102,707 | 12,067 | 11.75% |
04-01-2024 | $1.72 | $1.6 | $1.7203 | $1.53 | 122,551 | 13,818 | 11.28% |
03-28-2024 | $1.5 | $1.66 | $1.7 | $1.5 | 137,093 | 34,674 | 25.29% |
News, Short Squeeze, Breakout and More Instantly...
Aptose Biosciences Inc. Company Name:
APTO Stock Symbol:
NASDAQ Market:
Aptose Biosciences Inc. Website:
Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML Tuspetinib Continues Broad Activity Across Mutations with Excellent Safety Profile Luxeptinib G3 Formulation Achieves Desired Levels and Positions for Future Trials Conference Call ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
SAN DIEGO and TORONTO, March 18, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO, TSX:APS), a clinical- stage precision oncology c...